SignatureFD
AGIO icon

SignatureFD’s Agios Pharmaceuticals AGIO Stock Holding History

SignatureFD’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.3K Hold
399
– – ﹤0.01% 2608
2026
Q2 		$14.8K Hold
399
– – ﹤0.01% 2479
2026
Q1 		$13.5K Hold
399
– – ﹤0.01% 2380
2025
Q4 		$10.9K Sell
399
-114
-22% -$4K ﹤0.01% 2396
2025
Q3 		$20.6K Hold
513
– – ﹤0.01% 2101
2025
Q2 		$17.1K Buy
513
+36
+8% +$1.09K ﹤0.01% 2124
2025
Q1 		$14K Sell
477
-34
-7% -$1.13K ﹤0.01% 2228
2024
Q4 		$16.8K Buy
511
+11
+2% +$517 ﹤0.01% 2141
2024
Q3 		$22.2K Buy
500
+12
+2% +$545 ﹤0.01% 1990
2024
Q2 		$21K Sell
488
-5
-1% -$180 ﹤0.01% 1944
2024
Q1 		$14.4K Sell
493
-200
-29% -$5.36K ﹤0.01% 2164
2023
Q4 		$15.4K Buy
693
+22
+3% +$493 ﹤0.01% 2054
2023
Q3 		$16.6K Sell
671
-68
-9% -$1.8K ﹤0.01% 1947
2023
Q2 		$20.9K Sell
739
-28
-4% -$697 ﹤0.01% 1860
2023
Q1 		$17.6K Sell
767
-214
-22% -$5.68K ﹤0.01% 1938
2022
Q4 		$27.5K Sell
981
-22
-2% -$620 ﹤0.01% 1649
2022
Q3 		$28K Buy
1,003
+482
+93% +$12.9K ﹤0.01% 1571
2022
Q2 		$12K Buy
521
+402
+338% +$9.08K ﹤0.01% 2016
2022
Q1 		$3K Buy
119
+74
+164% +$2.26K ﹤0.01% 2649
2021
Q4 		$1K Sell
45
-28
-38% -$1.13K ﹤0.01% 2857
2021
Q3 		$3K Sell
73
-105
-59% -$5.07K ﹤0.01% 2493
2021
Q2 		$10K Buy
178
+68
+62% +$3.8K ﹤0.01% 1968
2021
Q1 		$6K Buy
110
+37
+51% +$1.83K ﹤0.01% 2044
2020
Q4 		$3K Hold
73
– – ﹤0.01% 2097
2020
Q3 		$3K Buy
73
+35
+92% +$1.53K ﹤0.01% 2039
2020
Q2 		$2K Buy
38
+2
+6% +$93 ﹤0.01% 2072
2020
Q1 		$1K Sell
36
-18
-33% -$832 ﹤0.01% 2056
2019
Q4 		$3K Buy
54
+36
+200% +$1.36K ﹤0.01% 1746
2019
Q3 		$1K Sell
18
-31
-63% -$1.28K ﹤0.01% 1907
2019
Q2 		$2K Buy
49
+21
+75% +$1.12K ﹤0.01% 1733
2019
Q1 		$2K Buy
+28
New +$1.63K ﹤0.01% 1748

Other funds holding AGIO

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SCS Capital Management
SCS Capital Management Boston, Massachusetts $11.2B AUM 12.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

SignatureFD's AGIO Position: Q3 2026 in Review

SignatureFD held its Agios Pharmaceuticals (AGIO) position steady in Q3 2026 at 399 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

SignatureFD first reported a position in AGIO in Q1 2019 and has held it in 31 quarters since. The position peaked at $28K in Q3 2022. 142 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • SignatureFD held 399 shares of Agios Pharmaceuticals worth $13.3K as of Q3 2026.
  • SignatureFD left its Agios Pharmaceuticals share count unchanged in Q3 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2608 holding.
  • SignatureFD first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 31 quarters since.
  • SignatureFD's Agios Pharmaceuticals position peaked at $28K in Q3 2022.
  • 142 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.